Results
|
|
121.
|
Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane. [electronic resource] by
- Kaufman, Peter A
- Awada, Ahmad
- Twelves, Chris
- Yelle, Louise
- Perez, Edith A
- Velikova, Galina
- Olivo, Martin S
- He, Yi
- Dutcus, Corina E
- Cortes, Javier
Producer: 20150414
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 33
Availability: No items available.
|
|
|
122.
|
Irinotecan, oxaliplatin, and 5-fluorouracil/leucovorin combination chemotherapy in advanced colorectal carcinoma: a phase II study. [electronic resource] by
- Calvo, Emiliano
- Cortés, Javier
- Rodríguez, Javier
- Fernández-Hidalgo, Oscar
- Rebollo, Joseba
- Martín-Algarra, Salvador
- García-Foncillas, Jesús
- Martínez-Monge, Rafael
- de Irala, Jokin
- Brugarolas, Antonio
Producer: 20030109
In:
Clinical colorectal cancer vol. 2
Availability: No items available.
|
|
|
123.
|
[Consensus statement on biomarkers in breast cancer by the Spanish Society of Pathology and the Spanish Society of Medical Oncology]. [electronic resource] by
- Palacios Calvo, José
- Albanell, Joan
- Rojo, Federico
- Ciruelos, Eva
- Aranda-López, Ignacio
- Cortés, Javier
- García-Caballero, Tomás
- Martín, Miguel
- López-García, María Ángeles
- Colomer, Ramon
Producer: 20190321
In:
Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia vol. 51
Availability: No items available.
|
|
|
124.
|
Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004. [electronic resource] by
- Somlo, George
- Atzori, Francesco
- Strauss, Lewis C
- Geese, William J
- Specht, Jennifer M
- Gradishar, William J
- Rybicki, Alissa
- Sy, Oumar
- Vahdat, Linda T
- Cortes, Javier
Producer: 20130927
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 19
Availability: No items available.
|
|
|
125.
|
Contextualizing pertuzumab approval in the treatment of HER2-positive breast cancer patients. [electronic resource] by
- Cortés, Javier
- Ciruelos, Eva
- Pérez-García, José
- Albanell, Joan
- García-Estévez, Laura
- Ruiz-Borrego, Manuel
- Espinosa, Ruth
- Gallegos, Isabel
- González, Santiago
- Álvarez, Isabel
- Llombart, Antonio
Producer: 20200123
In:
Cancer treatment reviews vol. 83
Availability: No items available.
|
|
|
126.
|
|
|
|
127.
|
Phase 2 Study of Trabectedin in Patients With Hormone Receptor-Positive, HER-2-Negative, Advanced Breast Carcinoma According to Expression of Xeroderma Pigmentosum G Gene. [electronic resource] by
- Awada, Ahmad
- Cortés, Javier
- Martín, Miguel
- Aftimos, Philippe
- Oliveira, Mafalda
- López-Tarruella, Sara
- Espie, Marc
- Lardelli, Pilar
- Extremera, Sonia
- Fernández-García, Eva M
- Delaloge, Suzette
Producer: 20170717
In:
Clinical breast cancer vol. 16
Availability: No items available.
|
|
|
128.
|
IMpassion132 Phase III trial: atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer. [electronic resource] by
- Cortés, Javier
- André, Fabrice
- Gonçalves, Anthony
- Kümmel, Sherko
- Martín, Miguel
- Schmid, Peter
- Schuetz, Florian
- Swain, Sandra M
- Easton, Valerie
- Pollex, Erika
- Deurloo, Regula
- Dent, Rebecca
Producer: 20200106
In:
Future oncology (London, England) vol. 15
Availability: No items available.
|
|
|
129.
|
High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin-but not with treatment of physician's choice-in the EMBRACE study. [electronic resource] by
- Miyoshi, Yasuo
- Yoshimura, Yuta
- Saito, Kenichi
- Muramoto, Kenzo
- Sugawara, Michiko
- Alexis, Karenza
- Nomoto, Kenichi
- Nakamura, Seigo
- Saeki, Toshiaki
- Watanabe, Junichiro
- Perez-Garcia, Jose Manuel
- Cortes, Javier
Producer: 20210111
In:
Breast cancer (Tokyo, Japan) vol. 27
Availability: No items available.
|
|
|
130.
|
Genetic evolution of nevus of Ota reveals clonal heterogeneity acquiring BAP1 and TP53 mutations. [electronic resource] by
- Vivancos, Ana
- Caratú, Ginevra
- Matito, Judit
- Muñoz, Eva
- Ferrer, Berta
- Hernández-Losa, Javier
- Bodet, Domingo
- Pérez-Alea, Mileidys
- Cortés, Javier
- Garcia-Patos, Vicente
- Recio, Juan A
Producer: 20161110
In:
Pigment cell & melanoma research vol. 29
Availability: No items available.
|
|
|
131.
|
Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer. [electronic resource] by
- Scaltriti, Maurizio
- Rojo, Federico
- Ocaña, Alberto
- Anido, Judit
- Guzman, Marta
- Cortes, Javier
- Di Cosimo, Serena
- Matias-Guiu, Xavier
- Ramon y Cajal, Santiago
- Arribas, Joaquin
- Baselga, José
Producer: 20070430
In:
Journal of the National Cancer Institute vol. 99
Availability: No items available.
|
|
|
132.
|
"New" metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapy. [electronic resource] by
- Twelves, Christopher
- Cortes, Javier
- Kaufman, Peter A
- Yelle, Louise
- Awada, Ahmad
- Binder, Terri A
- Olivo, Martin
- Song, James
- O'Shaughnessy, Joyce A
- Jove, Maria
- Perez, Edith A
Producer: 20180111
In:
Breast cancer research : BCR vol. 17
Availability: No items available.
|
|
|
133.
|
A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: an analysis of the ATHENA trial. [electronic resource] by
- Llombart-Cussac, Antonio
- Pivot, Xavier
- Biganzoli, Laura
- Cortes-Funes, Hernan
- Pritchard, Kathleen I
- Pierga, Jean-Yves
- Smith, Ian
- Thomssen, Christoph
- Srock, Stefanie
- Sampayo, Miguel
- Cortes, Javier
Producer: 20150622
In:
Breast (Edinburgh, Scotland) vol. 23
Availability: No items available.
|
|
|
134.
|
Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy. [electronic resource] by
- Baselga, José
- Gelmon, Karen A
- Verma, Shailendra
- Wardley, Andrew
- Conte, Pierfranco
- Miles, David
- Bianchi, Giulia
- Cortes, Javier
- McNally, Virginia A
- Ross, Graham A
- Fumoleau, Pierre
- Gianni, Luca
Producer: 20100325
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 28
Availability: No items available.
|
|
|
135.
|
HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer. [electronic resource] by
- Miller, Kathy
- Cortes, Javier
- Hurvitz, Sara A
- Krop, Ian E
- Tripathy, Debu
- Verma, Sunil
- Riahi, Kaveh
- Reynolds, Joseph G
- Wickham, Thomas J
- Molnar, Istvan
- Yardley, Denise A
Producer: 20171030
In:
BMC cancer vol. 16
Availability: No items available.
|
|
|
136.
|
TROPiCS-02: A Phase III study investigating sacituzumab govitecan in the treatment of HR+/HER2- metastatic breast cancer. [electronic resource] by
- Rugo, Hope S
- Bardia, Aditya
- Tolaney, Sara M
- Arteaga, Carlos
- Cortes, Javier
- Sohn, Joohyuk
- Marmé, Frederik
- Hong, Quan
- Delaney, Rosemary J
- Hafeez, Amir
- André, Fabrice
- Schmid, Peter
Producer: 20210201
In:
Future oncology (London, England) vol. 16
Availability: No items available.
|
|
|
137.
|
Modulation of telomere protection by the PI3K/AKT pathway. [electronic resource] by
- Méndez-Pertuz, Marinela
- Martínez, Paula
- Blanco-Aparicio, Carmen
- Gómez-Casero, Elena
- Belen García, Ana
- Martínez-Torrecuadrada, Jorge
- Palafox, Marta
- Cortés, Javier
- Serra, Violeta
- Pastor, Joaquin
- Blasco, Maria A
Producer: 20181001
In:
Nature communications vol. 8
Availability: No items available.
|
|
|
138.
|
Drug interaction potential of trastuzumab emtansine (T-DM1) combined with pertuzumab in patients with HER2-positive metastatic breast cancer. [electronic resource] by
- Lu, Dan
- Burris, Howard A
- Wang, Bei
- Dees, E Claire
- Cortes, Javier
- Joshi, Amita
- Gupta, Manish
- Yi, Joo-Hee
- Chu, Yu-Waye
- Shih, Ted
- Fang, Liang
- Girish, Sandhya
Producer: 20130613
In:
Current drug metabolism vol. 13
Availability: No items available.
|
|
|
139.
|
Open-label, phase II, multicenter, randomized study of the efficacy and safety of two dose levels of Pertuzumab, a human epidermal growth factor receptor 2 dimerization inhibitor, in patients with human epidermal growth factor receptor 2-negative metastatic breast cancer. [electronic resource] by
- Gianni, Luca
- Lladó, Anna
- Bianchi, Giulia
- Cortes, Javier
- Kellokumpu-Lehtinen, Pirkko-Liisa
- Cameron, David A
- Miles, David
- Salvagni, Stefania
- Wardley, Andrew
- Goeminne, Jean-Charles
- Hersberger, Veronica
- Baselga, José
Producer: 20100325
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 28
Availability: No items available.
|
|
|
140.
|
Combined irinotecan, oxaliplatin and 5-fluorouracil in patients with advanced colorectal cancer. a feasibility pilot study. [electronic resource] by
- Calvo, Emiliano
- Cortés, Javier
- González-Cao, María
- Rodríguez, Javier
- Aramendía, José Manuel
- Fernández-Hidalgo, Oscar
- Martín-Algarra, Salvador
- Salgado, José Esteban
- Martínez-Monge, Rafael
- de Irala, Jokin
- Brugarolas, Antonio
Producer: 20021212
In:
Oncology vol. 63
Availability: No items available.
|